vs
GRAFTECH INTERNATIONAL LTD（EAF）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是GRAFTECH INTERNATIONAL LTD的1.8倍（$219.9M vs $125.1M），Orthofix Medical Inc.净利率更高（-1.0% vs -34.6%，领先33.6%），GRAFTECH INTERNATIONAL LTD同比增速更快（11.9% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-27.1M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -4.6%）
格瑞泰克国际有限公司是石墨电极与石油焦生产商，其产品是电弧炉炼钢及其他金属生产的核心原材料。公司总部位于俄亥俄州布鲁克林海茨，在法国加来、西班牙潘普洛纳、墨西哥蒙特雷以及美国宾夕法尼亚州圣玛丽斯均设有生产基地。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
EAF vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.8倍
$125.1M
营收增速更快
EAF
高出9.9%
2.0%
净利率更高
OFIX
高出33.6%
-34.6%
自由现金流更多
OFIX
多$43.9M
$-27.1M
两年增速更快
OFIX
近两年复合增速
-4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $125.1M | $219.9M |
| 净利润 | $-43.3M | $-2.2M |
| 毛利率 | -7.8% | 71.1% |
| 营业利润率 | — | 0.2% |
| 净利率 | -34.6% | -1.0% |
| 营收同比 | 11.9% | 2.0% |
| 净利润同比 | -10.0% | 92.4% |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EAFOFIX
| Q1 26 | $125.1M | — | ||
| Q4 25 | $116.5M | $219.9M | ||
| Q3 25 | $144.0M | $205.6M | ||
| Q2 25 | $131.8M | $203.1M | ||
| Q1 25 | $111.8M | $193.6M | ||
| Q4 24 | $134.2M | $215.7M | ||
| Q3 24 | $130.7M | $196.6M | ||
| Q2 24 | $137.3M | $198.6M |
净利润EAFOFIX
| Q1 26 | $-43.3M | — | ||
| Q4 25 | $-65.1M | $-2.2M | ||
| Q3 25 | $-28.5M | $-22.8M | ||
| Q2 25 | $-86.9M | $-14.1M | ||
| Q1 25 | $-39.4M | $-53.1M | ||
| Q4 24 | $-49.5M | $-29.1M | ||
| Q3 24 | $-36.1M | $-27.4M | ||
| Q2 24 | $-14.8M | $-33.4M |
毛利率EAFOFIX
| Q1 26 | -7.8% | — | ||
| Q4 25 | -20.9% | 71.1% | ||
| Q3 25 | 7.2% | 72.2% | ||
| Q2 25 | 0.0% | 68.7% | ||
| Q1 25 | -1.5% | 62.8% | ||
| Q4 24 | -7.8% | 69.0% | ||
| Q3 24 | -9.2% | 68.7% | ||
| Q2 24 | 2.9% | 67.8% |
营业利润率EAFOFIX
| Q1 26 | — | — | ||
| Q4 25 | -33.6% | 0.2% | ||
| Q3 25 | -3.6% | -8.3% | ||
| Q2 25 | -11.0% | -7.9% | ||
| Q1 25 | -16.3% | -25.2% | ||
| Q4 24 | -18.6% | -5.3% | ||
| Q3 24 | -20.1% | -9.6% | ||
| Q2 24 | -2.0% | -12.5% |
净利率EAFOFIX
| Q1 26 | -34.6% | — | ||
| Q4 25 | -55.9% | -1.0% | ||
| Q3 25 | -19.8% | -11.1% | ||
| Q2 25 | -65.9% | -6.9% | ||
| Q1 25 | -35.2% | -27.4% | ||
| Q4 24 | -36.9% | -13.5% | ||
| Q3 24 | -27.6% | -13.9% | ||
| Q2 24 | -10.7% | -16.8% |
每股收益（稀释后）EAFOFIX
| Q1 26 | — | — | ||
| Q4 25 | $-6.86 | $-0.05 | ||
| Q3 25 | $-1.10 | $-0.57 | ||
| Q2 25 | $-0.34 | $-0.36 | ||
| Q1 25 | $-0.15 | $-1.35 | ||
| Q4 24 | $-3.51 | $-0.76 | ||
| Q3 24 | $-1.40 | $-0.71 | ||
| Q2 24 | $-0.06 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $120.2M | $82.0M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | — | $450.0M |
| 总资产 | $997.2M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EAFOFIX
| Q1 26 | $120.2M | — | ||
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | $120.7M | $26.4M |
总债务EAFOFIX
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $157.2M | ||
| Q2 25 | $1.1B | $157.0M | ||
| Q1 25 | $1.1B | $156.9M | ||
| Q4 24 | $1.1B | $157.0M | ||
| Q3 24 | $929.5M | $118.5M | ||
| Q2 24 | $928.2M | $118.0M |
股东权益EAFOFIX
| Q1 26 | — | — | ||
| Q4 25 | $-259.6M | $450.0M | ||
| Q3 25 | $-194.4M | $442.5M | ||
| Q2 25 | $-168.4M | $458.3M | ||
| Q1 25 | $-105.3M | $458.3M | ||
| Q4 24 | $-78.9M | $503.1M | ||
| Q3 24 | $-9.0M | $525.9M | ||
| Q2 24 | $16.2M | $546.0M |
总资产EAFOFIX
| Q1 26 | $997.2M | — | ||
| Q4 25 | $1.0B | $850.6M | ||
| Q3 25 | $1.1B | $832.6M | ||
| Q2 25 | $1.1B | $837.2M | ||
| Q1 25 | $1.2B | $823.1M | ||
| Q4 24 | $1.2B | $893.3M | ||
| Q3 24 | $1.1B | $867.9M | ||
| Q2 24 | $1.2B | $882.0M |
负债/权益比EAFOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | 57.16× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-27.1M | $16.8M |
| 自由现金流率自由现金流/营收 | -21.6% | 7.6% |
| 资本支出强度资本支出/营收 | 9.7% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-105.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流EAFOFIX
| Q1 26 | $-14.9M | — | ||
| Q4 25 | $-20.9M | $27.7M | ||
| Q3 25 | $24.7M | $12.4M | ||
| Q2 25 | $-53.2M | $11.6M | ||
| Q1 25 | $-32.2M | $-18.4M | ||
| Q4 24 | $-26.4M | $23.7M | ||
| Q3 24 | $23.7M | $11.7M | ||
| Q2 24 | $-36.9M | $9.0M |
自由现金流EAFOFIX
| Q1 26 | $-27.1M | — | ||
| Q4 25 | $-39.3M | $16.8M | ||
| Q3 25 | $18.4M | $2.5M | ||
| Q2 25 | $-57.1M | $4.5M | ||
| Q1 25 | $-42.5M | $-25.1M | ||
| Q4 24 | $-39.2M | $15.2M | ||
| Q3 24 | $19.7M | $6.3M | ||
| Q2 24 | $-43.8M | $-360.0K |
自由现金流率EAFOFIX
| Q1 26 | -21.6% | — | ||
| Q4 25 | -33.7% | 7.6% | ||
| Q3 25 | 12.8% | 1.2% | ||
| Q2 25 | -43.3% | 2.2% | ||
| Q1 25 | -38.0% | -13.0% | ||
| Q4 24 | -29.2% | 7.0% | ||
| Q3 24 | 15.1% | 3.2% | ||
| Q2 24 | -31.9% | -0.2% |
资本支出强度EAFOFIX
| Q1 26 | 9.7% | — | ||
| Q4 25 | 15.8% | 4.9% | ||
| Q3 25 | 4.4% | 4.8% | ||
| Q2 25 | 3.0% | 3.5% | ||
| Q1 25 | 9.2% | 3.5% | ||
| Q4 24 | 9.5% | 4.0% | ||
| Q3 24 | 3.1% | 2.7% | ||
| Q2 24 | 5.1% | 4.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EAF
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
